Back to search

Article

The JAK inhibitor, Tofacitinib, Corrects the Overexpression of CEACAM6 and Limits Susceptibility to AIEC Caused by Reduced Activity of the IBD Associated Gene,<i>PTPN2</i>

2024-09-28

Abstract excerpt

<h4>Background and Aims</h4> A cohort of patients with inflammatory bowel disease (IBD) exhibit expansion of the gut pathobiont, adherent-invasive E. coli (AIEC). Loss of activity of the IBD susceptibility gene, protein tyrosine phosphatase type 2 ( PTPN2 ), results in dysbiosis of the gut microbiota both in human subjects and mice. Further, constitutive Ptpn2 knock-out ( Ptpn2 -KO) mice display expansion of AIEC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e069437a-2983-5f8d-8c82-1e76d3edbb52
DOI
10.1101/2024.09.26.24314341
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The JAK inhibitor, Tofacitinib, Corrects the Overexpression of CEACAM6 and Limits Susceptibility to AIEC Caused by Reduced Activity of the IBD Associated Gene,<i>PTPN2</i>DOI 10.1101/2024.09.26.24314341
Select a neighboring publication to make it the new centre.